Utilize este identificador para referenciar este registo:
https://hdl.handle.net/10316/109917
Título: | Mesenchymal transition and PDGFRA amplification/mutation are key distinct oncogenic events in pediatric diffuse intrinsic pontine gliomas | Autor: | Puget, Stephanie Philippe, Cathy Bax, Dorine A. Job, Bastien Varlet, Pascale Junier, Marie-Pierre Andreiuolo, Felipe Carvalho, Dina Reis, Ricardo Guerrini-Rousseau, Lea Roujeau, Thomas Dessen, Philippe Richon, Catherine Lazar, Vladimir Le Teuff, Gwenael Sainte-Rose, Christian Geoerger, Birgit Vassal, Gilles Jones, Chris Grill, Jacques |
Data: | 2012 | Editora: | Public Library of Science | Projeto: | Canceropole Ile de France – Institut National de Cancer (INCa) LEM-Recherche (Les Entreprises du Médicament) association ‘‘L’Etoile de Martin Association pour la Recherche en Neurochirurgie Pe´diatrique (ARNP) |
Título da revista, periódico, livro ou evento: | PLoS ONE | Volume: | 7 | Número: | 2 | Resumo: | Diffuse intrinsic pontine glioma (DIPG) is one of the most frequent malignant pediatric brain tumor and its prognosis is universaly fatal. No significant improvement has been made in last thirty years over the standard treatment with radiotherapy. To address the paucity of understanding of DIPGs, we have carried out integrated molecular profiling of a large series of samples obtained with stereotactic biopsy at diagnosis. While chromosomal imbalances did not distinguish DIPG and supratentorial tumors on CGHarrays, gene expression profiling revealed clear differences between them, with brainstem gliomas resembling midline/thalamic tumours, indicating a closely-related origin. Two distinct subgroups of DIPG were identified. The first subgroup displayed mesenchymal and pro-angiogenic characteristics, with stem cell markers enrichment consistent with the possibility to grow tumor stem cells from these biopsies. The other subgroup displayed oligodendroglial features, and appeared largely driven by PDGFRA, in particular through amplification and/or novel missense mutations in the extracellular domain. Patients in this later group had a significantly worse outcome with an hazard ratio for early deaths, ie before 10 months, 8 fold greater that the ones in the other subgroup (p = 0.041, Cox regression model). The worse outcome of patients with the oligodendroglial type of tumors was confirmed on a series of 55 paraffin-embedded biopsy samples at diagnosis (median OS of 7.73 versus 12.37 months, p = 0.045, log-rank test). Two distinct transcriptional subclasses of DIPG with specific genomic alterations can be defined at diagnosis by oligodendroglial differentiation or mesenchymal transition, respectively. Classifying these tumors by signal transduction pathway activation and by mutation in pathway member genes may be particularily valuable for the development of targeted therapies. | URI: | http://hdl.handle.net/10316/109917 | ISSN: | 1932-6203 | DOI: | 10.1371/journal.pone.0030313 | Direitos: | openAccess |
Aparece nas coleções: | I&D CNC - Artigos em Revistas Internacionais |
Ficheiros deste registo:
Ficheiro | Descrição | Tamanho | Formato | |
---|---|---|---|---|
Mesenchymal-transition-and-pdgfra-amplificationmutation-are-key-distinct-oncogenic-events-in-pediatric-diffuse-intrinsic-pontine-gliomasPLoS-ONE.pdf | 1.49 MB | Adobe PDF | Ver/Abrir |
Visualizações de página
36
Visto em 28/ago/2024
Downloads
26
Visto em 28/ago/2024
Google ScholarTM
Verificar
Altmetric
Altmetric
Este registo está protegido por Licença Creative Commons